Similar articles

• Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.

  Shigemasa K, Tian X, Gu L, Shiroyama Y, Nagai N, Ohama K. Shigemasa K, et al. Int J Oncol. 2003 Jan;22(1):99-105. Int J Oncol. 2003. PMID: 12469191
• [Expression of cyclooxygenase-2 in ovarian carcinoma and its significance].

  Luo WZ, Shen J, Zhang Y, Lang JH. Luo WZ, et al. Zhonghua Yi Xue Za Zhi. 2004 Aug 17;84(16):1374-6. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15637815 Chinese. No abstract available.
• [COX-2 expression and ovarian cancer].

  Uzunova E, Kornovski Ia, Tsvetkov Ts, Ianeva R. Uzunova E, et al. Akush Ginekol (Sofiia). 2005;44(4):31-3. Akush Ginekol (Sofiia). 2005. PMID: 16028376 Review. Bulgarian.
• [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].

  Zang T, Sun F, Li Y. Zang T, et al. Zhonghua Wai Ke Za Zhi. 2001 Sep;39(9):702-3. Zhonghua Wai Ke Za Zhi. 2001. PMID: 11769607 Chinese.
• Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma.

  O'Byrne KJ, Edwards JG, Waller DA. O'Byrne KJ, et al. Lung Cancer. 2004 Aug;45 Suppl 1:S45-8. doi: 10.1016/j.lungcan.2004.04.025. Lung Cancer. 2004. PMID: 15261433 Review.